Medicare at 50: Its Effect on Disparities

This Forum presentation provides an overview of the historical impact of the Medicare with emphasis on key milestones related to reducing health disparities. Recent challenges related to ACA are also discussed. Objectives: Review the history of legislation leading to development of the Medicare program in the U.S Delineate key Medicare milestones Identify recent changes in Medicare Define the impact on disparities and quality of care Presentation: 47:48 Note: PowerPoint slides are at bottom of pag

Medicare at Fifty Years: Impact on Health Care Disparities

Objectives: To review history of legislation to development of Medicare program in the United States To delineate key Medicare milestones To review recent changes in Medicare To define impact on disparities An examination of the history of Medicare and its impact on our ability to deliver patient-centered, interprofessional care. A description of global interprofessional education and practice, highlighting real world examples from the work of Partners In Health in West Africa and Haiti

Associations Between Oncogenic Risk Markers and Clinical Outcomes among Black and White Colorectal Cancer Patients

Introduction: Blacks have a 25% higher incidence of colorectal cancer compared to their white societal counterparts. Additionally, the overall mortality rate among black colorectal cancer patients is 50% higher than that of whites. However, little is known about the biomarkers prevalent among blacks and their possible correlation to treatment response and patient outcomes. Objective: The objective of this study is to explore disease trends that may unveil a correlation between molecular markers and poor clinical outcomes among black colorectal cancer patients. Methods: De-identified patient data was obtained from The Oncology Data Services Department (Cancer Registry) of TJUH. The population cohort included newly diagnosed colorectal cancer patients treated at TJUH from 2000-2019, and included information regarding patient race, sex, age at presentation, stage at presentation, histological code, tumor markers: KRAS, NRAS, BRAF, MS1, treatment received, surgical findings: tumor size, lymph node involvement, presence of distant metastases at first surgery, response to chemotherapy & disease-free survival. Results: Preliminary data on the analyzed population demonstrates that biomarker profiles did not correlate with patient race. Therefore, racial disparities seen among colorectal cancer patients cannot be attributed to these findings. Conclusion: Biomarker trends among newly diagnosed colorectal cancer patients at TJUH do not correlate with racial identity. Additional data is needed regarding possible etiologies for the comparatively higher incidence and mortality rates among black colorectal cancer patients. Health professionals should continue to explore possible etiologies for this racial disparity in future studies

Precision Medicine in Colorectal Cancer: Molecular Factors to Optimize Systemic Therapeutic Decisions and Patient Care

Learning Objectives: To review progress over the past 50 years in the diagnosis and treatment of colorectal cancer To discuss etiology, biology, and emerging use of biomakers To provide an overview of treatment strategies and parameters Presentation: 56 minute